Home > Research > Researchers > Professor Christian Holscher > Publications

Professor Christian Holscher

Formerly at Lancaster University

  1. Published

    (Val⁸) glucagon-like peptide-1 prevents tau hyperphosphorylation, impairment of spatial learning and ultra-structural cellular damage induced by streptozotocin in rat brains

    Li, L., Zhang, Z-F., Hölscher, C., Gao, C., Jiang, Y-H. & Liu, Y-Z., 15/01/2012, In: European Journal of Pharmacology. 674, 2-3, p. 280-286 7 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  2. Published

    A novel bioresorbable device as a controlled release system for protecting cells from oxidative stress from Alzheimer’s Disease

    Salles, G. N., Pereira, F. A. D. S., Pacheco-Soares, C., Marciano, F. R., Holscher, C., Webster, T. J. & Lobo, A. O., 11/2017, In: Molecular Neurobiology. 54, 9, p. 6827-6838 12 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  3. Published

    A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson’s disease by reducing chronic inflammation in the brain

    Lijun, C., Li, D., Feng, P., Li, L., Xue, G., Li, G. & Holscher, C., 13/04/2016, In: NeuroReport. 27, 6, p. 384-391 8 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  4. Published

    A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson′s disease by increasing expression of BNDF

    Ji, C., Xue, G-F., Lijun, C., Feng, P., Li, D., Li, L., Li, G. & Holscher, C., 1/03/2016, In: Brain Research. 1634, p. 1-11 11 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  5. Published

    A novel dual GLP-1/GIP receptor agonist alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv. STZ rat model

    Shi, L., Zhang, Z. & Hölscher, C., 1/06/2017, In: Behavioural Brain Research. 327, p. 65-74 10 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  6. Published

    A novel dual-glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist is neuroprotective in transient focal cerebral ischemia in the rat

    Han, L., Holscher, C., Xue, G., Li, G. & Li, D., 6/01/2016, In: NeuroReport. 27, 1, p. 23-32 10 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  7. Published

    A novel GLP-1/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinson's disease

    Yuan, Z., Li, D., Feng, P., Xue, G., Ji, C., Li, G. & Hölscher, C., 5/10/2017, In: European Journal of Pharmacology. 812, p. 82-90 9 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  8. Published

    A novel GLP-1/GIP dual receptor agonist protects from 6-OHDA lesion in a rat model of Parkinson's disease

    Jalewa, J., Sharma, M. K., Gengler, S. & Hölscher, C., 1/05/2017, In: Neuropharmacology. 117, p. 238-248 11 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  9. Published

    Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet

    Gault, V. A., Porter, W. D., Flatt, P. R. & Holscher, C., 08/2010, In: International Journal of Obesity. 34, p. 1341-1344 4 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  10. Published

    Acylated Ghrelin as a Multi-Targeted Therapy for Alzheimer's and Parkinson's Disease.

    Reich, N. & Hölscher, C., 14/12/2020, In: Frontiers in Neuroscience. 14, 35 p., 614828.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  11. Published

    Age-associated changes of brain copper, iron, and zinc in Alzheimer's disease and dementia with Lewy bodies

    Graham, S. F., Nasaruddin, M. B., Carey, M., Holscher, C., McGuinness, B., Kehoe, P. G., Love, S., Passmore, P., Elliott, C. T., Meharg, A. A. & Green, B. D., 2014, In: Journal of Alzheimer's Disease. 42, 4, p. 1407-1413 7 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  12. Published

    Alzheimer's disease–like pathology has transient effects on the brain and blood metabolome

    Pan, X., Nasaruddin, M. B., Elliott, C. T., McGuinness, B., Passmore, A. P., Kehoe, P. G., Holscher, C., McClean, P. L., Graham, S. F. & Green, B. D., 02/2016, In: Neurobiology of Aging. 38, p. 151-163 13 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  13. Published

    An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers

    Bomfim, T. R., Forny-Germano, L., Sathler, L. B., Brito-Moreira, J., Houzel, J-C., Decker, H., Silverman, M. A., Kazi, H., Melo, H. M., McClean, P. L., Holscher, C., Arnold, S. E., Talbot, K., Klein, W. L., Munoz, D. P., Ferreira, S. T. & De Felice, F. G., 2/04/2012, In: Journal of Clinical Investigation. 122, 4, p. 1339-1353 15 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  14. Published

    Are Alzheimer's disease and other neurodegenerative disorders caused by impaired signalling of insulin and other hormones?

    Hölscher, C., De Felice, F. G., Greig, N. & Ferreira, S. T., 1/07/2018, In: Neuropharmacology. 136, Part B, p. 159 1 p.

    Research output: Contribution to Journal/MagazineEditorialpeer-review

  15. Published

    Beneficial actions of glucagon-like peptide 1 (GLP-1) on hippocampal synaptic plasticity, gene expression, oxidative stress and inflammation in mice with diet-induced obesity and insulin resistance

    Gault, V., Lennox, R., Porter, D., Holscher, C. & Flatt, P., 03/2013, In: Diabetic Medicine. 30, Supplement 1, p. 4 1 p., A9 (P99).

    Research output: Contribution to Journal/MagazineMeeting abstractpeer-review

  16. Published

    Beyond appetite: Acylated ghrelin as a learning, memory and fear behavior-modulating hormone

    Reich, N. & Hölscher, C., 31/12/2022, In: Neuroscience and Biobehavioral Reviews. 143, 27 p., 104952.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  17. Published

    Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases

    Holscher, C., 1/04/2014, In: Journal of Endocrinology. 221, p. T31-T41 11 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  18. Published

    Chronic treatment with the GLP1 analogue liraglutide increases cell proliferation and differentiation into neurons in an AD mouse model

    Parthsarathy, V. & Holscher, C., 11/03/2013, In: PLoS ONE. 8, 3, e58784.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  19. Published

    Comparison of the independent and combined effects of sub-chronic therapy with metformin and a stable GLP-1 receptor agonist on cognitive function, hippocampal synaptic plasticity and metabolic control in high-fat fed mice

    Lennox, R., Porter, D. W., Flatt, P. R., Holscher, C., Irwin, N. & Gault, V. A., 11/2014, In: Neuropharmacology. 86, p. 22-30 9 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  20. Published

    DA5-CH, a novel GLP-1/GIP dual agonist, effectively ameliorates the cognitive impairments and pathology in the APP/PS1 mouse model of Alzheimer's disease

    Cao, Y., Hölscher, C., Hu, M-M., Wang, T., Zhao, F., Bai, Y., Zhang, J., Wu, M-N. & Qi, J-S., 15/05/2018, In: European Journal of Pharmacology. 827, p. 215-226 12 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  21. Published

    DA-JC1 improves learning and memory by antagonizing Aβ31-35-induced circadian rhythm disorder

    Wang, L., Zhang, R., Hou, X., Wang, C., Guo, S., Ning, N., Sun, C., Yuan, Y., Li, L., Hölscher, C. & Wang, X., 11/02/2019, In: Molecular Brain. 12, 1, 14 p., 12.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  22. Published

    D-Ala2GIP facilitated synaptic plasticity and reduces plaque load in aged wild type mice and in an Alzheimer’s disease mouse model

    Faivre, E. & Holscher, C., 8/04/2013, In: Journal of Alzheimer's Disease. 35, 2, p. 267-283 17 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  23. Published

    D-Ala2-GIP-glu-PAL is neuroprotective in a chronic Parkinson's disease mouse model and increases BNDF expression while reducing neuroinflammation and lipid peroxidation

    Li, Y., Liu, W., Li, L. & Holscher, C., 15/02/2017, In: European Journal of Pharmacology. 797, p. 162-172 11 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  24. Published

    Diabetes as a risk factor for Alzheimer’s disease: insulin signalling impairment in the brain as an alternative model of Alzheimer’s disease

    Holscher, C., 08/2011, In: Biochemical Society Transactions. 39, 4, p. 891-897 7 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  25. Published

    Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis

    Hunter, K. & Holscher, C., 2012, In: BMC Neuroscience. 13, p. 33-38 6 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

Previous 1 2 3 4 5 Next

Back to top